Municipal strength and margin initiatives offset residential weakness, but elevated SG&A is limiting EBITDA growth.
| Quarter | Q3 FY25 |
|---|---|
| Call date | 2025-12-10 |
| Length | 61 minutes |
| EPS | $0.69 |
| EPS consensus | $0.65 |
| Revenue | $2.1B |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q4 FY25 · Q2 FY25
All CNM earnings · Back to CNM overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.